SCHEMBL2653059

SCHEMBL2653059

COC(=O)CCNC(=O)c1ccc(CCCCCCCOc2ccc(O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.53
RAB9A P51151 5/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ESRRG P62508 2/20 0.52
MAPT P10636 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
CNR2 P34972 2/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
ESRRB O95718 1/20 0.48
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
GFER P55789 1/20 0.47
ALDH1A1 P00352 1/20 0.47
S1PR1 P21453 2/20 0.46
S1PR3 Q99500 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2661669 0.91 NPC1 (0.62) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2654532 0.90 HSP90AA1 (0.53) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2654708 0.90 HSP90AA1 (0.53) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2655192 0.89 NPC1 (0.60) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2655517 0.89 HSP90AA1 (0.54) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2654896 0.88 S1PR1 (0.60) NPC1RAB9AMEN1KMT2AESRRG
SCHEMBL2652991 0.88 NPC1 (0.53) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2656353 0.87 ESRRG (0.55) NPC1RAB9AMEN1KMT2AESRRG
SCHEMBL2652925 0.87 NPC1 (0.49) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2654356 0.86 NPC1 (0.53) NPC1RAB9AMEN1KMT2AESRRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed